help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hulthén, L.
Right arrow Articles by Johannsson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hulthén, L.
Right arrow Articles by Johannsson, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 10 4765-4770
Copyright © 2001 by The Endocrine Society


Other Original Articles

GH Is Needed for the Maturation of Muscle Mass and Strength in Adolescents

Lena Hulthén, Bengt-Åke Bengtsson, Katharina Stibrant Sunnerhagen, Leif Hallberg, Gunnar Grimby and Gudmundur Johannsson

Research Centre for Endocrinology and Metabolism (G.J., B.-Å.B.), Department of Clinical Nutrition (L.Hu., L.Ha.), and Department of Rehabilitation Medicine (K.S.S., G.G.), Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden

Abstract

The postpubertal period and the early years of adulthood may be of importance for continuing tissue maturation of importance in adulthood and aging. An example of this is the peak bone mass. This study has evaluated the importance of GH for lean mass and muscle strength in adolescents and young adults. GH treatment was discontinued in 40 adolescents aged 16–21 yr with GH deficiency of childhood onset. Measurements of isometric and isokinetic knee-extensor and flexor strength, handgrip strength, lean body mass, fat-free mass, and total body nitrogen were performed annually for 2 yr. Two hundred fifty healthy adolescents were randomly selected for prospective measurements of lean mass and handgrip strength between the ages of 17 and 21 yr. In the adolescents with continuing GH deficiency, lean body mass decreased, compared with the patients defined as having sufficient endogenous GH. The isometric strength in knee flexors increased in the sufficient endogenous GH group and was unchanged in the GH deficiency group during the 2 yr off GH treatment (between group, P < 0.05). The mean and peak handgrip strength increased on average by 9–15% in the group with sufficient endogenous GH and was unchanged in those with GH deficiency (P < 0.05). Lean body mass and handgrip strength (both, P < 0.001) increased in both the healthy boys and girls who were followed for 4 yr with a more marked increase in the boys. The mean increase in handgrip between the age of 17 and 21 yr was 7–9%. The increased lean mass and improved muscle performance seen in healthy adolescents did not occur in adolescents with GH deficiency. These findings suggest that GH is of importance for the maturation of lean mass and muscle strength in adolescents and young adults.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. Radovick and S. DiVall
Approach to the Growth Hormone-Deficient Child during Transition to Adulthood
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1195 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Svensson, G. Johannsson, A. Iranmanesh, K. Albertsson-Wikland, J. D Veldhuis, and B.-A. Bengtsson
GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood.
Eur. J. Endocrinol., July 1, 2006; 155(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho
Estrogen Regulation of Growth Hormone Action
Endocr. Rev., October 1, 2004; 25(5): 693 - 721.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A J van der Lely
Justified and unjustified use of growth hormone
Postgrad. Med. J., October 1, 2004; 80(948): 577 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. V. Carroll, W. M. Drake, K. T. Maher, K. Metcalfe, N. J. Shaw, D. B. Dunger, T. D. Cheetham, C. Camacho-Hubner, M. O. Savage, and J. P. Monson
Comparison of Continuation or Cessation of Growth Hormone (GH) Therapy on Body Composition and Metabolic Status in Adolescents with Severe GH Deficiency at Completion of Linear Growth
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3890 - 3895.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Boot
Body Composition and Bone Mineral Density in Adolescents with Partial Growth Hormone Deficiency
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5099 - 5100.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. F. Attanasio, S. Howell, P. C. Bates, P. Frewer, J. Chipman, W. F. Blum, and S. M. Shalet
Body Composition, IGF-I and IGFBP-3 Concentrations as Outcome Measures in Severely GH-Deficient (GHD) Patients after Childhood GH Treatment: A Comparison with Adult Onset GHD Patients
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3368 - 3372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society